Cliff Asness's GMED Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 118,086 shares of Globus Medical, Inc. (GMED) worth $10.31 M, representing 0.01% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in GMED, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 922,160 shares. Largest reduction occurred in Q3 2019, reducing 508,409 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +42,577 | Add 56.39% | 118,086 | $87.31 |
| Q3 2025 | -36,492 | Reduce 32.58% | 75,509 | $56.21 |
| Q2 2025 | +89,491 | Add 397.56% | 112,001 | $58.88 |
| Q1 2025 | +7,086 | Add 45.94% | 22,510 | $72.07 |
| Q4 2024 | +490 | Add 3.28% | 15,424 | $82.71 |
| Q3 2024 | -307 | Reduce 2.01% | 14,934 | $70.47 |
| Q2 2024 | +228 | Add 1.52% | 15,241 | $68.49 |
| Q1 2024 | -50,808 | Reduce 77.19% | 15,013 | $53.64 |
| Q4 2023 | -102,310 | Reduce 60.85% | 65,821 | $53.29 |
| Q3 2023 | -17,193 | Reduce 9.28% | 168,131 | $49.65 |
| Q2 2023 | +63,158 | Add 51.70% | 185,324 | $59.45 |
| Q1 2023 | +35,479 | Add 40.93% | 122,166 | $55.95 |
| Q4 2022 | -16,677 | Reduce 16.13% | 86,687 | $73.55 |
| Q3 2022 | -27,553 | Reduce 21.05% | 103,364 | $59.57 |
| Q2 2022 | -49,113 | Reduce 27.28% | 130,917 | $55.97 |
| Q1 2022 | +4,520 | Add 2.58% | 180,030 | $73.78 |
| Q4 2021 | +32,486 | Add 22.71% | 175,510 | $72.20 |
| Q3 2021 | -15,516 | Reduce 9.79% | 143,024 | $76.62 |
| Q2 2021 | -60,171 | Reduce 27.51% | 158,540 | $76.54 |
| Q1 2021 | +12,927 | Add 6.28% | 218,711 | $61.45 |
| Q4 2020 | -242,380 | Reduce 54.08% | 205,784 | $64.41 |
| Q3 2020 | -355,633 | Reduce 44.24% | 448,164 | $49.17 |
| Q2 2020 | -179,401 | Reduce 18.25% | 803,797 | $47.15 |
| Q1 2020 | -219,649 | Reduce 18.26% | 983,198 | $42.24 |
| Q4 2019 | -283,870 | Reduce 19.09% | 1.2 M | $58.76 |
| Q3 2019 | -508,409 | Reduce 25.48% | 1.49 M | $51.09 |
| Q2 2019 | -218,281 | Reduce 9.86% | 2 M | $42.30 |
| Q1 2019 | -291,883 | Reduce 11.65% | 2.21 M | $48.63 |
| Q4 2018 | +109,721 | Add 4.58% | 2.51 M | $43.28 |
| Q3 2018 | +169,823 | Add 7.63% | 2.4 M | $56.76 |
| Q2 2018 | +922,160 | Add 70.74% | 2.23 M | $50.46 |
| Q1 2018 | +251,639 | Add 23.92% | 1.3 M | $49.82 |
| Q4 2017 | -3,550 | Reduce 0.34% | 1.05 M | $41.10 |
| Q3 2017 | +526,721 | Add 99.61% | 1.06 M | $29.72 |
| Q2 2017 | +400,530 | Add 312.31% | 528,776 | $33.15 |
| Q1 2017 | +29,471 | Add 29.84% | 128,246 | $29.62 |
| Q4 2016 | -18,725 | Reduce 15.94% | 98,775 | $24.80 |
| Q3 2016 | +29,079 | Add 32.89% | 117,500 | $22.57 |
| Q2 2016 | +47,727 | Add 117.28% | 88,421 | $23.83 |
| Q1 2016 | -10,704 | Reduce 20.83% | 40,694 | $23.74 |
| Q4 2015 | -15,565 | Reduce 23.24% | 51,398 | $27.82 |
| Q3 2015 | -37,318 | Reduce 35.79% | 66,963 | $20.67 |
| Q2 2015 | -50,012 | Reduce 32.41% | 104,281 | $25.67 |
| Q1 2015 | -37,400 | Reduce 19.51% | 154,293 | $25.24 |
| Q4 2014 | -29,907 | Reduce 13.50% | 191,693 | $23.77 |
| Q3 2014 | -31,600 | Reduce 12.48% | 221,600 | $19.67 |
| Q2 2014 | +190,500 | Add 303.83% | 253,200 | $23.92 |
| Q1 2014 | +62,700 | New Buy | 62,700 | $26.59 |
Cliff Asness's Globus Medical Investment FAQs
Cliff Asness first purchased Globus Medical, Inc. (GMED) in Q1 2014, acquiring 62,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Globus Medical, Inc. (GMED) for 48 quarters since Q1 2014.
Cliff Asness's largest addition to Globus Medical, Inc. (GMED) was in Q2 2018, adding 2,225,746 shares worth $112.31 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 118,086 shares of Globus Medical, Inc. (GMED), valued at approximately $10.31 M.
As of the Q4 2025 filing, Globus Medical, Inc. (GMED) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Globus Medical, Inc. (GMED) was 2,505,290 shares, as reported at the end of Q4 2018.